Navigation Links
Strategic Diagnostics Reports Fourth Quarter and Full-Year Financial Results
Date:2/28/2008

e third

quarter and content is being added weekly.

- Expansion of the Company's Molecular Biology Lab in Dallas and

its facility in Newark, Delaware in response to growth in demand

for both GAT and conventional hybridoma development. This follows

the expansion of the Company's Windham, Maine antibody production

facility during November 2007, which increased capacity for

polyclonal antibody production by 44%.

-- SDI reported the sixth consecutive quarter of double digit

year-over-year growth in the antibody business.

-- SDI reported the third consecutive quarter of more than 20%

year-over-year growth in the food pathogen testing products area.

Matthew H. Knight, the Company's President and Chief Executive Officer, commented, "SDI has emerged as an established leader in the production of high-value antibody-based reagents used in the diagnosis of disease, and our antibody business, based on our new Genomic Antibody Technology(TM), is gaining widespread adoption in proteomic research, as well as drug/biomarker discovery among academic, biotech and large pharmaceutical customers. We reported our sixth consecutive quarter of double-digit year-over-year revenue growth in antibody-related revenue and this part of our business is becoming an increasingly important component of our overall revenue and profitability. For the quarter, antibody revenues expanded to 53% of total revenue compared to 43% in the fourth quarter of 2006."

Financial Highlights

In 000s Q4 Q4

2007 2006

Revenues $7,271 $6,990

Gross Profit 4,396 3,902

SG&A Expense 3,329
'/>"/>

SOURCE Strategic Diagnostics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
2. Strategic Diagnostics Updates Roth Conference Presentation Time
3. Heritage and Ipca Enter Into Strategic Alliance for Generic Pharmaceutical Products
4. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
5. PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development
6. Genstar Names Michael Hurt to Its Strategic Advisory Board
7. Pharsight Expands Strategic Consulting Services Team
8. VaxGen Further Restructures to Preserve Cash as It Pursues Strategic Initiatives
9. Campbell Alliance to Moderate Senior-Level Panel Discussion at Windhover Pharmaceutical Strategic Alliances Conference
10. Keryx Biopharmaceuticals, Inc. Announces Conference Call to Discuss Strategic Alliance
11. AEterna Zentaris Announces Outcome of Managements Strategic Review
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)...  Axovant Sciences Ltd. (NYSE:  AXON), a leading ... dementia, today announced that the company will host ... p.m. EDT following its presentation of RVT-101 clinical ... (AAIC). The event will include ... Lawrence Friedhoff , Chief Development Officer, will present ...
(Date:7/1/2015)... ... , ... A newly launched business plan contest will ask startup companies from ... life sciences R&D. The Pistoia Alliance President’s Startup Challenge 2015 will see small and ... of expert mentorship from a senior industry figure drawn from the Pistoia Alliance membership. ...
(Date:7/1/2015)... ... July 01, 2015 , ... Apex Therapeutics announced today that ... in Philadelphia, PA. , The presentation took place on Tuesday, June 16 ... for the development of APX3330 for the treatment of pancreatic cancer. A copy ...
(Date:7/1/2015)... 2015  UCB, a multinational biopharmaceutical company, and ... in designing, transforming, and running intelligent business operations, ... of their close collaboration in driving transformation that ... services (GBS) finance organization. The Aecus ... work together effectively to embrace the innovative promise ...
Breaking Biology Technology:Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 2Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 3Pistoia Alliance Launches Startup Challenge 2Pistoia Alliance Launches Startup Challenge 3Apex Therapeutics Presented Company Overview at This Year’s BIO International Convention in Philadelphia, PA 2UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 2UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 3UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 4UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 5
... Iowa Patricia Thiel of Iowa State University and the Ames ... of coasters to the middle and a trinket box to the ... lots of little things." So Thiel grabbed the smaller things and ... box. "Nature wants one big thing all together, like this." ...
... 2010 Cannabis Science, Inc. (OTC Bulletin Board: ... pharmaceutical cannabis products announced today that regardless of the ... electoral issues throughout the country, it is apparent that ... more important than ever, as the demand for the ...
... Inc. (NYSE Amex: PIP ), a biodefense ... announced today that the Company was awarded four separate ... Project, enacted as part of the Patient Protection and ... is a benefit targeted to small business therapeutic discovery ...
Cached Biology Technology:Iowa State, Ames Laboratory scientists advance the understanding of the big getting bigger 2Proposition 19 Decision Prompts Cannabis Science to Anticipate Increased Demand for its Pharmaceutical Products for Critical Ailments and Begin the Formal Application Process for FDA Clinical Trials Immediately 2Proposition 19 Decision Prompts Cannabis Science to Anticipate Increased Demand for its Pharmaceutical Products for Critical Ailments and Begin the Formal Application Process for FDA Clinical Trials Immediately 3PharmAthene Receives Four Therapeutic Discovery Project Grants Totaling Approximately $850,000 2PharmAthene Receives Four Therapeutic Discovery Project Grants Totaling Approximately $850,000 3
(Date:6/30/2015)... -- Genisphere announced Tom Bliss ... develop Genisphere,s therapeutics capabilities and portfolio. Mr. Bliss comes ... of the last 25 years in leadership positions at ... & Johnson. Tom started his career in Investment Banking, ... He graduated from Dartmouth College with a BA in ...
(Date:6/25/2015)... SALT LAKE CITY , June 25, 2015 /PRNewswire/ ... the first steps toward a healthier, happier life. That,s ... app is designed to do. The cutting-edge, portable health ... and offers real-life solutions to help improve your lifestyle ... Sellers Association awards dinner and gala Wednesday night, USANA,s ...
(Date:6/24/2015)... Calif. , June 24, 2015  Synaptics ... of human interface solutions, today announced that Sharp ... to provide secure authentication for its latest flagship ... reached more than 200 million shipments of its ... Sharp reinforces Synaptics, strength, scalability and leadership in ...
Breaking Biology News(10 mins):Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2
... Lymphoma Protected by SPAK Silencing A group led ... of the protein SPAK may contribute to B-cell lymphoma development. ... issue of the American Journal of Pathology . ... system cancers. Epigenetic changes, such as DNA hypermethylation, may ...
... Consortium (PGSC), an international team of scientists from industry ... sequence of the potato genome with the help of ... horticulture in the College of Agriculture and Life Sciences ... potato variety that accelerated the development of a blueprint ...
... 2009Using clever chemistry, a Scripps Research team has pinpointed ... the progression of the devastating disease Friedreich,s ataxia in ... findings, developed in collaboration with scientists from Repligen Corporation, ... human clinical trials, which will be a welcome event ...
Cached Biology News:Tips from the American Journal of Pathology 2Tips from the American Journal of Pathology 3Tips from the American Journal of Pathology 4Tips from the American Journal of Pathology 5Draft potato genome based on unique potato variety 2Mechanism for potential Friedreich's ataxia drug uncovered 2Mechanism for potential Friedreich's ataxia drug uncovered 3
... tested through 63 ligand ... spanning a broad therapeutic ... includes many non human ... non-selective assays. Used ...
... The Genome Sequencer 20 System revolutionizes ... massively parallel fashion. The Genome Sequencer ... accessories Reagents and consumables for library ... for mapping and de novo assembly ...
Compound(s) tested through a broad panel of 38 ligand binding and enzyme assays targeting the Central Nervous System. Used to determine selectivity and potential CV/Renal liabilities of compounds....
... Human serum is obtained from normal human ... by a test for Human Immunodeficiency Virus ... Virus (Anti-HIV 1/2), Hepatitis C Virus (HCV), ... (HbsAg) and Non-reactive by a screening test ...
Biology Products: